Somatostatin receptor PET imaging has shown a significant improvement over conventional imaging. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors.
This AUC is part of a new series developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for Advanced Diagnostic Imaging. The society's other recently released AUC are for bone scintigraphy in prostate and breast cancer; ventilation/perfusion (V/Q) imaging in pulmonary embolism, which is endorsed by the American College of Emergency Physicians; hepatobiliary scintigraphy in abdominal pain; and FDG PET/CT restaging and response assessment of malignant disease.
PET Imaging Could Detect, Treat Pancreatic Cancer
Theranostic agent combines diagnostic and therapeutic capabilities into a single agent for treating malignancies by expressing the cancer antigen 19-9.
Advertisement
‘The appropriate use criteria (AUC) document is available in the January 2018 issue of the Journal of Nuclear Medicine and features 12 different clinical scenarios for the technology.’
Tweet it Now
The AUC for somatostatin receptor PET imaging addresses several clinical scenarios for diagnosing neuroendocrine tumors (NETs).
To develop these criteria, SNMMI worked collaboratively with the European Association of Nuclear Medicine (EANM), the European Neuroendocrine Tumor Society (ENETS), the American Gastroenterological Association (AGA), the American Society of Clinical Oncology (ASCO), the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN), the American Joint Committee on Cancer (AJCC), the North American Neuroendocrine Tumor Society (NANETS), the National Cancer Institute (NCI), the Endocrine Society, the American Association of Engineering Societies (AAES), and the Society of Surgical Oncology (SSO).
![Novel PET Imaging Identifies Primary and Metastatic Prostate Cancer]( "Novel PET Imaging Identifies Primary and Metastatic Prostate Cancer")
An effective and specific imaging method of detecting both primary and metastatic lesions is thus of critical importance to manage patients with prostate cancer.
SNMMI assembled an autonomous Somatostatin Receptor PET Imaging in Neuroendocrine Tumors Workgroup consisting of experts in the field of nuclear medicine including radiologists, pharmacologists, endocrinologists, surgeons and oncologists to review the scientific literature and develop consensus recommendations for the clinical use of this technology. The Oregon Health Science University's (OHSU) Evidence-based Practice Center (EPC) conducted a systematic review of existing evidence based on the scope and parameters that the workgroup put together, which were then used to make the recommendations for clinical use.
The SNMMI Guidance Oversight Committee is also developing AUC for gastrointestinal transit, infection imaging, PET myocardial perfusion imaging, prostate cancer imaging, and thyroid imaging and therapy.
Source: Eurekalert
Novel PET Imaging Identifies Primary and Metastatic Prostate Cancer
An effective and specific imaging method of detecting both primary and metastatic lesions is thus of critical importance to manage patients with prostate cancer.
Advertisement
SNMMI assembled an autonomous Somatostatin Receptor PET Imaging in Neuroendocrine Tumors Workgroup consisting of experts in the field of nuclear medicine including radiologists, pharmacologists, endocrinologists, surgeons and oncologists to review the scientific literature and develop consensus recommendations for the clinical use of this technology. The Oregon Health Science University's (OHSU) Evidence-based Practice Center (EPC) conducted a systematic review of existing evidence based on the scope and parameters that the workgroup put together, which were then used to make the recommendations for clinical use.
The SNMMI Guidance Oversight Committee is also developing AUC for gastrointestinal transit, infection imaging, PET myocardial perfusion imaging, prostate cancer imaging, and thyroid imaging and therapy.
Source: Eurekalert
Novel Approach for Quantifying Olfactory Neuron Populations With PET Imaging
A technique that is able to quantify the olfactory neuron population could provide important insights related to neurodegenerative diseases.
Advertisement
 PET Imaging Technology to Improve Patient's Response to Cancer TreatmentYears of significant improvements in PET imaging technology have led to the detection of an enzyme in humans that plays a significant role in DNA formation. | Advertisement
|
Advertisement
Latest General Health News
The Japanese parliament approved a bill allowing medical cannabis products and prohibiting their use for non-medicinal purposes.
Most Americans confess that due to constant flurry of activity during the holiday season, it is difficult to eat nutritiously, exercise, and get enough sleep.
People who suffer from depression, constipation, and urinary tract infections are more likely to get multiple sclerosis(MS) five years before MS diagnosis.
Seeking internet help for an incomplete antibiotic course resulted in kidney stone formation and urinary tract infection in a young woman.
The Brain Care Score is a tool to evaluate brain health and reduce the risk of brain disorders including dementia and stroke.